Scientists at Florida International University may have found a way to make a powerful cancer treatment work even better. The ...
Researchers at the University of Maryland School of Medicine (UMSOM) have identified a target that may improve the response ...
Morning Overview on MSN
Disabling a single protein called NFIL3 kept CAR T-cells fighting tumors longer in a screen of 400 transcription factors
Researchers screening roughly 400 transcription factors found that disabling a single protein, NFIL3, allowed CAR T-cells to ...
T cells are a major component to the immune system. They are responsible for identifying and targeting foreign material and ...
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company ...
In a new study published in Science titled, “Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity,” researchers from St. Jude Children’s Research Hospital have ...
(NASDAQ: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers (TCEs) for cancer and autoimmune diseases, today announced the ...
Background Chronic hepatitis B virus (HBV) infection disproportionately affects people living with HIV, who are often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results